Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Vetter Offers Answers for the Future at the Pharma Congress 2013

Published: Tuesday, February 19, 2013
Last Updated: Tuesday, February 19, 2013
Bookmark and Share
Experts from the CDMO to discuss the challenges and solutions facing the industry.

Changing markets and potential solutions will be the highlight at the 15th Pharma Congress Production & Technology in Duesseldorf, Germany, March 19 - 20. Vetter, one of the worlds’ leading Contract and Development Manufacturing Organization, will present on a variety of informative core developments critical to the international pharmaceutical and biotech industries. Udo J. Vetter, chairman of the Vetter advisory board, will present the keynote address at the Congress focusing his comments on the future demands and challenges in pharmaceutical manufacturing. Vetter experts will address various topics including the needs for filling monoclonal antibodies, advantages and solutions of restricted access barrier systems (RABS) and the implementation of isolators for sterility tests as well as Vetter’s own supplier management system and the company’s new Center for Visual Inspection and Logistics.

Major changes taking place among the world’s leading pharmaceutical and biotech companies demand creative solutions to complex challenges by the manufacturing industry. The 15th Pharma Congress Production & Technology held in mid-March, will bring together representatives from the private and public sectors to discuss the current market trends. Vetter, an international specialist in aseptic filling, will present on best practices in sterile manufacturing and packaging.

Presenter and topics include Udo J. Vetter, who will be focusing on aseptic manufacturing at the Congress's keynote. The chairman of the Vetter advisory board will be speaking about the current market trends and their long-term effects on sterile production. He will also discuss changing technological and regulatory requirements and how innovative and flexible production plants can provide answers.

Joerg Zimmermann, Director Process Development and Implementation will present two case studies including Vetter’s experiences with fill-and-finish considerations for monoclonal antibodies and how certain challenges are already being met in the early phases. His second case study will cover the function and advantages of the restricted access barrier systems (RABS) in aseptic manufacturing and how to operate a RABS-based line successfully based on real life experience. Mr. Zimmermann will also moderate the ECA Barrier Systems Conference, one of the key sessions of the Congress.

Dr. Andreas Reicke, Team Coordinator at Vetter’s microbiology division will review a case study on the implementation of sterility test isolators. He will talk about regulatory demands and considerations in regards to design, location and utilities as well as project planning from beginning through to implementation.

Uli Kuchenbrod, Director Incoming Goods at Vetter, will give his insights into Vetter‘s supplier management system and incoming inspections as part of quality control. He will also address the operative challenges as well as the strategic considerations between a CDMO and its suppliers.

Thomas Ruebekeil, Director Investment Projects will introduce the new Vetter Ravensburg site. He will present the project plan and best practice as well as provide an update on the Center for Visual Inspection and Logistics including characteristics of the building itself and the use of regenerative energy and how it can be safely and efficiently used in the pharmaceutical sector.

All of the presentations are consistent with the goal of the international event which is to present lectures as technical applications "from users for users", primarily concentrating on their practical benefits.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Vetter Development Service Chicago Completes Recent On-Site Expansion Activities
Continued demand and increased customer product transfers are generating a positive business outlook for the company’s early-stage development facility.
Thursday, June 11, 2015
Vetter Serializes the First Product for South Korea
CDMO produces clearly identifiable labelling for a top-ten pharmaceutical company.
Saturday, May 02, 2015
Vetter Appoints Oliver Albrecht as Managing Director
Role with company commenced on April 1, 2015.
Thursday, April 09, 2015
Vetter Continues to Expand Capacity
Structural work completed on Vetter’s new multi-functional building for its Development Service and information technology (IT).
Friday, January 30, 2015
Vetter Adds Flexible Serialization Service to its Portfolio
A new service allowing for the explicit identification of drug packaging.
Thursday, December 04, 2014
Vetter Announces Opening of Office to Support Growing Asian Healthcare Market
New Asia Pacific office will support customer relations and the development of new business.
Friday, November 21, 2014
Vetter Announces Personnel Changes in its Development Service Division
Clinical manufacturing services continue to attract new business.
Saturday, October 18, 2014
Vetter Continues to Strengthen its Market Position
Another positive year for the CDMO.
Wednesday, January 15, 2014
Vetter to Construct New Filling Lines to Expand Capacity
Responding to customer demand and company growth.
Thursday, October 10, 2013
Vetter’s New Commercial Filling Line Ready for cGMP Filling
Novel, high-tech line fully validated; first customer project underway.
Monday, April 08, 2013
Vetter’s Newest Facility Successfully Completes FDA Inspection
Center for visual inspection and logistics sets high safety and control standards.
Thursday, March 28, 2013
Vetter’s Newest Facility Successfully Completes FDA Inspection
Center for visual inspection and logistics sets high safety and control standards.
Thursday, March 28, 2013
Vetter Receives “Known Consignor” Approval from Germany's Federal Aviation Office
The CDMO meets new requirements six months ahead of deadline.
Wednesday, December 12, 2012
Vetter Receives Top Prize at the European Outsourcing Awards Ceremony
CDMO clinches an industry Oscar for its innovative high-speed filling line.
Friday, October 12, 2012
Vetter’s Development Service Doubles its Revenues and Grows its Capabilities
Ravensburg development labs add enhanced technologies.
Friday, September 28, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Low-level Arsenic Exposure Before Birth Associated with Early Puberty in Female Mice
Study examine whether low-dose arsenic exposure could have similar health outcomes in humans.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
‘Mutation-Tracking’ Blood Test for Breast Cancer
Scientists have developed a blood test for breast cancer able to identify which patients will suffer a relapse after treatment, months before tumours are visible on hospital scans.
Cellular Contamination Pathway for Heavy Elements Identified
Berkeley Lab scientists find that an iron-binding protein can transport actinides into cells.
Intensity of Desert Storms May Affect Ocean Phytoplankton
MIT study finds phytoplankton are extremely sensitive to changing levels of desert dust.
Common ‘Heart Attack’ Blood Test May Predict Future Hypertension
Small rises in troponin levels may have value as markers for subclinical heart damage and high blood pressure.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!